Godha Cabcon IPO vs Indo US Bio-Tech IPO

Comparison between Godha Cabcon IPO and Indo US Bio-Tech IPO.

IPO Details

Godha Cabcon IPO is a SME Fixed Price IPO proposed to list at NSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Godha Cabcon IPO is up to ₹9.39 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Godha Cabcon IPO is ₹33.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.

 Godha Cabcon IPOIndo US Bio-Tech IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹30.00 per share
Issue Price (Upper)₹33.00 per share
Issue Price (Final)₹33.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares2000 shares
Fresh Issue Size28,44,000 shares13,56,000 shares
Fresh Issue Size (Amount)up to ₹9.39 Crup to ₹6.92 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total28,44,000 shares13,56,000 shares
Issue Size Total (Amount)up to ₹9.39 Crup to ₹6.92 Cr

IPO Timetable

Godha Cabcon IPO opens on Apr 27, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Godha Cabcon IPO and Indo US Bio-Tech IPO is May 03, 2018, and May 03, 2018, respectively.

 Godha Cabcon IPOIndo US Bio-Tech IPO
Issue OpenApr 27, 2018Apr 30, 2018
Issue CloseMay 03, 2018May 03, 2018
Basis Of Allotment (Tentative)May 10, 2018May 08, 2018
Listing date (Tentative)May 11, 2018May 11, 2018

Financials & KPIs

Godha Cabcon IPO P/E ratio is , as compared to Indo US Bio-Tech IPO P/E ratio of .

 Godha Cabcon IPOIndo US Bio-Tech IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Oct 201731 Mar 2017
Assets26.610.01
Total Income21.230.00
Profit After Tax0.93-0.00
NET Worth6.820.01
Reserves and Surplus0.93-0.00
Total Borrowing15.96
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Oct 201731 Mar 201731 Mar 201631 Mar 2015
Assets20.5612.9413.697.68
Total Income15.8924.5819.1519.66
Profit After Tax0.740.650.360.50
NET Worth4.633.893.252.90
Reserves and Surplus3.142.401.771.41
Total Borrowing6.394.864.671.67
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%100%
Promoter Shareholding (Post-Issue)72.97%70.54%
Market Cap₹36.63 Cr.₹24.76 Cr.

Shares Offered

In the Godha Cabcon IPO Retail Individual Investors (RII) are offered 9,94,000 shares while in Indo US Bio-Tech IPO retail investors are offered 9,94,000 shares. Qualified Institutional Buyers (QIB) are offered 14,20,000 shares in Godha Cabcon IPO and 0 shares in Indo US Bio-Tech IPO.

 Godha Cabcon IPOIndo US Bio-Tech IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,60,000 shares74,000 shares
QIB14,20,000 shares0 shares
NII4,26,000 shares6,78,000 shares
RII9,94,000 shares6,78,000 shares
Employee0 shares0 shares
Total28,40,000 shares13,56,000 shares

Bids Received (Subscription)

Godha Cabcon IPO subscribed 1.39x in total, whereas Indo US Bio-Tech IPO subscribed 19.69x.

 Godha Cabcon IPOIndo US Bio-Tech IPO
QIB (times)0.00x
NII (times)3.65x19.52x
RII (times)2.41x19.87x
Total (times)1.39x19.69x

Compare with others

Compare:

Godha Cabcon IPO Vs Indo US Bio-Tech IPO